Gaudium IVF and Women Health Limited
GAUDIUMIVF · NSE · ₹106 a share (close of 13 Nov 2026)
Available company data, source links and archived checks for Gaudium IVF and Women Health Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Net profit was ₹9.41 crore.
Quarter ended 2026-09-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Sep 2026 | Revenue: ₹37 cr | — | Net profit: ₹9 cr | — | 25.2% | Company filing source |
| Jun 2026 | Revenue: ₹19 cr | — | Net profit: ₹2 cr | — | 9.2% | Company filing source |
| Mar 2026 | Revenue: ₹30 cr | — | Net profit: ₹8 cr | — | 27.5% | Company filing source |
| Dec 2025 | Revenue: ₹25 cr | — | Net profit: ₹4 cr | — | 14.8% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Manika Khanna 70.7%GDN VENTURES LLP 4.3%MUKUL MAHAVIR AGRAWAL 3.4%SANSHI FUND-I 1.8%KISHAN GOPAL MOHTA 1.3%register as filed
2026-09-30
Filing timeline — what the company told the exchange
- Updates. Gaudium IVF and Women Health Limited has informed the Exchange regarding 'Rectification of inadvertent typographical error in the Unaudited Financial R
Company disclosure · 12 Nov 2026 · document
- Monitoring Agency Report for quarter ended September 30, 2026.
Company disclosure · 12 Nov 2026 · document
- Updates. Gaudium IVF and Women Health Limited has informed the Exchange regarding revised Code of Practices and Procedures for Fair Disclosure of Unpublished Pr
Company disclosure · 12 Nov 2026 · document
- Statement of deviation(s) or variation(s) under Reg. 32. Gaudium IVF and Women Health Limited has informed the Exchange about statement of deviation(s) or varia
Company disclosure · 12 Nov 2026 · document
- Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "Press Release on Unaudited Financial R
Company disclosure · 12 Nov 2026 · document
- Appointment of Mr. Ravish Manchanda, National Head Operations Expansion & Strategy, as Senior Management Personnel of the Company.
Company disclosure · 12 Nov 2026 · document
- Outcome of Board Meeting. Gaudium IVF and Women Health Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for th
Company disclosure · 12 Nov 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Gaudium IVF and Women Health Limited has informed the Exchange about Schedule of meet
Company disclosure · 11 Nov 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time